enGene Holdings: Looking For An End To The 2025 Decline (Downgrade)

When last I left enGene Holdings Inc. (NASDAQ: ENGN ) back in December , I came away with a rare "Strong Buy" sentiment on the prospect of their encouraging early data giving me unusual enthusiasticI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in th ...